We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Extend their Collaboration to Investigate the Immuno-Competence of Urothelial Cancer Patients Receiving Immunotherapy

Product News   Oct 23, 2018

 
The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Extend their Collaboration to Investigate the Immuno-Competence of Urothelial Cancer Patients Receiving Immunotherapy
 
 
FURTHER INFORMATION
 
 
 

Related Product News

TTP Ventus Introduces the XP Series of Micropumps

Product News

New micropump series offers improved performance, efficiency, and wider operating temperature range.

READ MORE


BIOCRATES Life Sciences AG Launches new Analytical Method for Functional Microbiome Research

Product News

Method Provides new Insights into the Interaction between the Host and Intestinal Flora.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE